New hope for kids with leukemia: early trial tests cutting-edge CAR-T treatment
NCT ID NCT07338357
Summary
This is an early-stage study to test the safety and see if a new type of CAR-T cell therapy might help children whose acute myeloid leukemia has come back or hasn't responded to other treatments. Doctors will collect a child's own immune cells, modify them in a lab to target a protein called CLL-1 on the leukemia cells, and then infuse them back. The main goal is to see if this approach is safe and shows any early signs of fighting the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AML (ACUTE MYELOID LEUKEMIA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.